Header

Automated storage for experiments

News Archive

Key Releases are ad hoc announcements pursuant to SIX Swiss Exchange Article 53 Listing Rules.

May 2022

Featured NewsMay 23, 2022
Novartis at ASCO and EHA 2022

April 2022

Featured NewsApr 26, 2022
Novartis Financial Results – Q1 2022
StatementApr 19, 2022
Novartis provides more than USD 25 million in medical aid to patients in Ukraine and bordering countries

March 2022

StatementMar 22, 2022
Novartis condemns the war in Ukraine - update March 22
StatementMar 18, 2022
COVID-19 news feed
StatementMar 08, 2022
Novartis expands humanitarian efforts in Ukraine through donation of essential medicines
StatementMar 04, 2022
Novartis condemns the war in Ukraine and commits to supporting humanitarian efforts

February 2022

January 2022

StatementJan 24, 2022
2021 Global Managed Access Program Community Update

December 2021

Pulse UpdateDec 16, 2021
Novartis receives FDA Fast Track designation for branaplam (LMI070) for the treatment of Huntington’s Disease